New Horizon Health Limited Stock price

Equities

6606

KYG6485S1021

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:30 2024-03-27 am EDT 5-day change 1st Jan Change
14.14 HKD -19.75% Intraday chart for New Horizon Health Limited -22.65% -38.92%

Financials

Sales 2023 * 1.87B 258M 2.02B Sales 2024 * 2.9B 401M 3.14B Capitalization 5.86B 811M 6.35B
Net income 2023 * 58M 8.03M 62.81M Net income 2024 * 352M 48.72M 381M EV / Sales 2023 * 2.59 x
Net cash position 2023 * 1.02B 141M 1.11B Net cash position 2024 * 707M 97.82M 765M EV / Sales 2024 * 1.78 x
P/E ratio 2023 *
91.5 x
P/E ratio 2024 *
17 x
Employees 1,041
Yield 2023 *
-
Yield 2024 *
-
Free-Float 73.95%
More Fundamentals * Assessed data
Dynamic Chart
1 day-19.75%
1 week-22.65%
Current month-30.69%
1 month-32.51%
3 months-34.54%
6 months-28.66%
Current year-38.92%
More quotes
1 week
13.76
Extreme 13.76
18.74
1 month
13.76
Extreme 13.76
21.95
Current year
13.76
Extreme 13.76
23.45
1 year
13.76
Extreme 13.76
32.55
3 years
12.70
Extreme 12.7
89.65
5 years
12.70
Extreme 12.7
89.65
10 years
12.70
Extreme 12.7
89.65
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 18-06-06
Founder - 18-06-06
Director of Finance/CFO 41 20-05-31
Members of the board TitleAgeSince
Founder - 18-06-06
Director/Board Member 54 21-02-16
Director/Board Member 54 20-10-08
More insiders
Date Price Change Volume
24-03-27 14.14 -19.75% 5,342,000
24-03-26 17.62 -5.27% 1,364,500
24-03-25 18.6 +1.20% 513,500
24-03-22 18.38 0.00% 1,074,000
24-03-21 18.38 +0.55% 611,600

Delayed Quote Hong Kong S.E., March 27, 2024 at 04:08 am EDT

More quotes
New Horizon Health Limited is a China-based investment holding company principally engaged in the research and development of screening products for colorectal cancer, cervical cancer and other types of cancer. The Company distributes its ColoClear, Pupu tube and other products to customers through its own network, contracted sales organisations (CSOs) and Internet sales or e-platform operated by healthcare clinics.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
13.06 CNY
Average target price
32.48 CNY
Spread / Average Target
+148.69%
Consensus
  1. Stock
  2. Equities
  3. Stock New Horizon Health Limited - Hong Kong S.E.